Fairfax

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Gastric and oesophageal cancer2 trials
• Liver and biliary tract cancer2 trials
• Lung cancer2 trials
• Melanoma2 trials
• Ovarian cancer2 trials
• Alzheimer disease1 trial
• Bladder cancer1 trial
• Cervical cancer1 trial
• Endometrial cancer1 trial
• Head and neck cancer1 trial
• High blood pressure1 trial
• and 4 more

Phase

• Phase 1/22 trials
• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Arvinas Inc.2 trials
• Alnylam Pharmaceuticals1 trial
• TrueBinding, Inc.1 trial

Running trials

• Recruiting

  A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  NCT07749586· Phase 1/2· Arvinas Inc.· Source

  Contact: Arvinas Inc.

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Active, not recruiting

  A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

  NCT07023731· Phase 1/2· Arvinas Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Cervical cancer1 recruiting
• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Ovarian cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Terminated

  A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

  NCT05476783· Phase 2· TrueBinding, Inc.· Source